• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄较大与经颈静脉肝内门体分流术后早期死亡率增加有关。

Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt.

作者信息

Saad Nael, Rude Mary Katherine, Darcy Michael, Hanin Jacob B, Wentworth Ashley, Korenblat Kevin M

机构信息

Vascular and Interventional Radiology and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO USA.

Hepatology Section, Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO USA.

出版信息

Ann Hepatol. 2016 Mar-Apr;15(2):215-221. doi: 10.5604/16652681.1193716.

DOI:10.5604/16652681.1193716
PMID:31196403
Abstract

INTRODUCTION & AIM: The role of age as a predictor of mortality after transjugular intra hepatic portosystemic shunt (TIPS) is controversial. Age has been found to be an important predictor of post-TIPS mortality in some, but not all, studies and is not a component of the MELD score. The purpose of this study was to compare the 90-day survival of subjects with cirrhosis age ≥ 70 years with younger subjects undergoing TIPS.

MATERIAL AND METHODS

A database of adult with cirrhosis undergoing TIPS from 2003-2011 was analyzed. The primary endpoint was survival 90-days post-TIPS. Survival was analyzed by the Kaplan-Meier method and proportional hazard modeling.

RESULTS

539 subjects met study criteria. 474 (88%) were between the ages of 24-69 and 65 (12%) were age 70-89 years. The groups were similar with respect to the indication for TIPS, mean MELD score and distribution of MELD score. Survival 90-days post-TIPS was 60% in the older cohort compared with 85% in the younger cohort (p < 0.001). Proportional hazards modeling controlled for comorbidities identified age ≥ 70 and MELD score as predictors of early post-TIPS survival. The hazard ratio associated with age increased monotonically, became significant at age ≥ 70 years (HR 3.22; 95% CI 1.81-5.74; p < 0.001) and exceeded the effect of MELD on survival.

CONCLUSIONS

Age ≥ 70 was associated with reduced survival within 90 days following TIPS. The findings from this study indicate that age is a relevant consideration in assessing the early mortality risk of TIPS.

摘要

引言与目的

年龄作为经颈静脉肝内门体分流术(TIPS)后死亡率的预测指标,其作用存在争议。在部分但并非所有研究中,年龄被发现是TIPS术后死亡率的重要预测指标,且不是终末期肝病模型(MELD)评分的组成部分。本研究的目的是比较年龄≥70岁的肝硬化患者与接受TIPS的年轻患者的90天生存率。

材料与方法

分析了2003年至2011年接受TIPS的成年肝硬化患者数据库。主要终点是TIPS术后90天的生存率。采用Kaplan-Meier法和比例风险模型分析生存率。

结果

539名受试者符合研究标准。474名(88%)年龄在24至69岁之间,65名(12%)年龄在70至89岁之间。两组在TIPS的适应证、平均MELD评分和MELD评分分布方面相似。老年队列TIPS术后90天生存率为60%,而年轻队列则为85%(p<0.001)。对合并症进行控制的比例风险模型确定年龄≥70岁和MELD评分是TIPS术后早期生存的预测指标。与年龄相关的风险比单调增加,在年龄≥70岁时变得显著(风险比3.22;95%置信区间1.81-5.74;p<0.001),且超过了MELD对生存的影响。

结论

年龄≥70岁与TIPS术后90天内生存率降低相关。本研究结果表明,在评估TIPS的早期死亡风险时,年龄是一个需要考虑的相关因素。

相似文献

1
Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt.年龄较大与经颈静脉肝内门体分流术后早期死亡率增加有关。
Ann Hepatol. 2016 Mar-Apr;15(2):215-221. doi: 10.5604/16652681.1193716.
2
Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.白蛋白-胆红素分级与 MELD 评分预测经颈静脉肝内门体分流术(TIPS)创建后的生存情况。
Diagn Interv Imaging. 2018 Mar;99(3):163-168. doi: 10.1016/j.diii.2017.10.008. Epub 2017 Nov 16.
3
Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.腰大肌密度联合终末期肝病模型评分可提高经颈静脉肝内门体分流术的生存预测能力。
J Vasc Interv Radiol. 2019 Feb;30(2):154-161. doi: 10.1016/j.jvir.2018.10.006.
4
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.经颈静脉肝内门体分流术治疗顽固性腹水:单中心经验
Scand J Gastroenterol. 2012 Dec;47(12):1494-500. doi: 10.3109/00365521.2012.703239. Epub 2012 Sep 10.
5
Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.经颈静脉肝内门体分流术治疗肝硬化症状性难治性肝性胸水。
Am J Gastroenterol. 2010 Mar;105(3):635-41. doi: 10.1038/ajg.2009.634. Epub 2009 Nov 10.
6
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.在预测经颈静脉肝内门体分流术患者生存率方面,Child-Pugh评分与终末期肝病模型(MELD)评分的比较
Gut. 2003 Jun;52(6):879-85. doi: 10.1136/gut.52.6.879.
7
A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.肝移植后门静脉-肝内分流术的安全性和有效性的病例对照研究。
Liver Transpl. 2011 Jul;17(7):771-8. doi: 10.1002/lt.22281.
8
MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.终末期肝病模型(MELD)评分作为接受择期经颈静脉肝内门体分流术(TIPS)患者早期死亡的预测指标。
Cardiovasc Intervent Radiol. 2005 May-Jun;28(3):307-12. doi: 10.1007/s00270-004-0145-y.
9
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.趋化因子(C-X-C基序)配体11水平可预测经颈静脉肝内门体分流术肝硬化患者的生存率。
Liver Int. 2016 Mar;36(3):386-94. doi: 10.1111/liv.12922. Epub 2015 Aug 17.
10
Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.不同评分系统对接受经颈静脉肝内门体分流术的中国肝硬化患者生存情况的预测
Eur J Gastroenterol Hepatol. 2014 Aug;26(8):853-60. doi: 10.1097/MEG.0000000000000134.

引用本文的文献

1
Association Between Older Age and TIPS-Related Hospitalization Following Shunt Placement.年龄较大与分流术后TIPS相关住院之间的关联。
Can J Gastroenterol Hepatol. 2025 May 21;2025:8894058. doi: 10.1155/cjgh/8894058. eCollection 2025.
2
Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.高龄作为经颈静脉肝内门体分流术患者预后预测指标的效用
Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08940-0.
3
The Value of Neutrophil-to-Lymphocyte Ratio in Predicting Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement.
中性粒细胞与淋巴细胞比值在预测经颈静脉肝内门体分流术术后死亡率中的价值
J Inflamm Res. 2024 Aug 1;17:5211-5221. doi: 10.2147/JIR.S467583. eCollection 2024.
4
Transjugular Intrahepatic Portosystemic Shunt Outcomes in the Elderly Population: A Systematic Review and Meta-Analysis.老年人群经颈静脉肝内门体分流术的结局:一项系统评价和荟萃分析
Gastroenterology Res. 2022 Dec;15(6):325-333. doi: 10.14740/gr1571. Epub 2022 Dec 1.
5
Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate.预防经颈静脉肝内门体分流术后肝性脑病:寻找理想的治疗方法。
Metab Brain Dis. 2023 Jun;38(5):1729-1736. doi: 10.1007/s11011-022-01131-0. Epub 2022 Nov 29.
6
Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.经颈静脉肝内门体分流术治疗难治性腹水和静脉曲张出血的决策:MELD,还是不 MELD,这是个问题。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e214-e222. doi: 10.1097/MEG.0000000000002009.
7
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
8
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.经颈静脉肝内门体分流术治疗肝硬化合并难治性腹水老年患者的安全性和可行性。
PLoS One. 2020 Jun 25;15(6):e0235199. doi: 10.1371/journal.pone.0235199. eCollection 2020.
9
Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older.70岁及以上肝硬化患者经颈静脉肝内门体分流术后的结局
J Clin Med. 2020 Jan 31;9(2):381. doi: 10.3390/jcm9020381.